Key Highlights
- TGA cautions delivery platforms; two major firms helped remove unlawful vape promotions.
- Therapeutic Goods Act 1989: public advertising of vapes prohibited; pharmacy-only sales.
- Tobacconists and c-stores cannot supply any vaping goods, with or without prescription.
- FY2024–25: TGA sought removal of 13,700+ ads/profiles; 8,500+ linked to nicotine/vaping.
- Penalties: up to AUD 2.31M (individuals), AUD 23.1M (corporations), or up to 7 years’ jail.
2Firsts, October 29, 2025 — According to the Therapeutic Goods Administration (TGA), the regulator has issued a clear warning to online delivery service providers not to breach Australian laws on the supply and advertising of vaping goods. Acting on complaints, the TGA worked with two well-known companies to identify and remove non-compliant material, underscoring its end-to-end compliance and enforcement role.
Professor Anthony Lawler, head of the TGA, said the agency takes all reports of non-compliance seriously, with a priority to reduce young people’s exposure to or access to illicit vapes online.
Under the Therapeutic Goods Act 1989, advertising vapes directly to the public is prohibited. Vapes may be sold only through pharmacies, and it is unlawful for tobacconists or convenience stores to supply any vaping goods, with or without a prescription.
The TGA monitors, detects and disrupts unlawful vape advertising. In 2024–25, it requested the removal of more than 13,700 advertisements or online profiles, including over 8,500 related to nicotine and vaping products. Where required, enforcement follows — infringement notices, seizures, and civil or criminal proceedings.
Non-compliance can attract significant penalties: up to AUD 2.31 million for individuals, AUD 23.1 million for corporations, or up to seven years’ imprisonment. The TGA encourages reports of unlawful vape sales and advertising.
Image source: Therapeutic Goods Administratio
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
